(Washington, D.C.) — Today, the U.S. House of Representatives passed a legislative package, SUPPORT for Patients and Communities Act (H.R. 6), which requires electronic prescribing (e-prescribing) of controlled substances in Medicare. This is an important step in the fight against America’s
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on a Medicare Part D report released today by the Office of Inspector (OIG), U.S. Department of Health and Human Services (HHS): “This report finally debunks the myth
A recent blog (“Payers and PBMs Profit from Obscure Pharmacy Fees, While Seniors See No Relief in Prescription Costs”) suggests performance-based price concessions are retained by PBMs, restrict the growth of independent pharmacies, and inflate Medicare Part D enrollee’s out-of-pocket costs—unfounded
With a nod to Dickens given that it’s the holidays, I’ve been thinking about biosimilars past, present and future lately. In that holiday spirit, even though the parallels aren’t perfect to the classic holiday story, let’s look at the biosimilar
(Washington, D.C.) — As independent drugstore lobbyists descend on Harrisburg for their lobby day, the Pharmaceutical Care Management Association (PCMA) released the following statement: “Pharmacy benefit managers (PBMs) advocate on behalf of Pennsylvania’s consumers and health plan sponsors by negotiating with drug manufacturers and
Unlocking an Affordable Future Unlocking an Affordable Future NEWSROOM PCMA Statement on Senate Judiciary Committee Hearing on Competition in The Prescription Drug Market NEWSROOM PCMA Statement on Senate Judiciary Committee Hearing on Competition in The Prescription Drug Market Stop The
Voices from around the nation, including small business owners and concerned citizens, have sounded the alarm on proposals targeting pharmacy benefit companies in Congress, specifically how policies would lead to increased health care costs for consumers, patients, and families, and
Pharmacy Benefit Managers reduce prescription drug costs for patients and use innovative technology to help patients get their prescriptions and lead healthier lives.
Between January 2022 and January 2023, the total number of independent pharmacies nationwide increased by 99, a 0.4% increase. Looking at the new five-year trend, the number of independent pharmacies has increased by 0.5%. Overall, the 2023 pharmacy counts have
(Washington, D.C.) — Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on the House Judiciary Committee’s markup of H.R. 2883, the “Stop Stalling Access to Affordable Medications”; H.R. 2891, the “Preserve Access to Affordable Generics
©2024 PCMA. All Rights Reserved.
